Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Temple University 2001
• 

  Duke Appointment History

  • Adjunct Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics, Basic Science Departments 2013
• Recognition
• 

  Awards & Honors

  • Fellow. American Statistical Association. 2016
• Expertise
• 

  Subject Headings

  • Breast Neoplasms
  • Cohort Studies
  • Colorectal Neoplasms
  • Gastrointestinal Hormones
  • Gastrointestinal Tract
  • Italy
  • Lung Neoplasms
  • Models, Statistical
  • Neoplasm Invasiveness
  • Prognosis
  • Socioeconomic Factors
  • Survival Analysis
  • Thyroid Neoplasms
  • Thyroidectomy
  • Urogenital System
• Research
• 

  Selected Grants

  • Epigenetic damage in women living in LA food-desert zip codes awarded by City of Hope 2017 - 2022
  • Comparison of Operative to Medical Endocrine Therapy (COMET) for Low Risk DCIS awarded by Alliance for Clinical Trials in Oncology Foundation 2016 - 2021
  • Translational Research in Surgical Oncology awarded by National Institutes of Health 2002 - 2021
  • IPA - Lin Gu awarded by Durham Veterans Affairs Medical Center 2017 - 2019
  • IPA - Terry Hyslop awarded by Durham Veterans Affairs Medical Center 2017 - 2019
  • Helicobacter pylori blood biomarker for gastric cancer risk in East Asia awarded by National Institutes of Health 2017 - 2019
  • Microscaled Proteogenomics for Cancer Clinical Trials awarded by Baylor College of Medicine 2017 - 2019
  • Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer awarded by National Institutes of Health 2017 - 2019
  • Innovative Biomarker-Integrated Clinical Trial Design and Analysis awarded by University of North Carolina - Chapel Hill 2015 - 2019
  • The Mathematics of Breast Cancer Overtreatment: Improving Treatment Choice through Effective Communication of Personalized Cancer Risk awarded by National Institutes of Health 2016 - 2018
  • Combined breast MRI/biomarker strategies to identify aggressive biology awarded by City of Hope 2015 - 2018
  • Tension-Stat3-miR-mediated Metastasis awarded by City of Hope 2015 - 2018
  • Breast Cancer Research Foundation awarded by Alliance for Clinical Trials in Oncology Foundation 2015 - 2017
  • National Clinical Trials Network - Network Group Statistics and DMCs awarded by Mayo Clinic 2014 - 2017
  • Tension-Stat3-miR-mediated Metastasis awarded by City of Hope 2015 - 2017
  • Single cell analysis of intratumoral heterogeneity in parathyroid neoplasia awarded by National Institutes of Health 2015 - 2017
  • Small RNA Sequencing and prospective evaluation of HCC risk in HBV patients awarded by Thomas Jefferson University 2014 - 2016
  • Combined breast MRI/biomarker strategies to identify aggressive biology awarded by National Institutes of Health 2015
  • Tension-Stat3-miR-mediated metastasis awarded by University of California - San Francisco 2015
  • Structural Models of Breast Cancer Outcomes Disparities awarded by Susan G Komen for the Cure 2014 - 2015
  • Therapy-relevant stratification of breast cancer patients: Integrating pathology and biomarkers analysis awarded by Thomas Jefferson University 2014 - 2015
  • Occult tumor burden as a marker stratifying therapy to eliminate racial disparities in colon cancer awarded by Thomas Jefferson University 2014
  • Tumor MicroRNA Signatures as Prognostic Biomarkers of Colorectal Cancer awarded by Thomas Jefferson University 2014
  • Therapeutic vaccine bridging the gap in racial disparities in colorectal cancer awarded by Thomas Jefferson University 2014
• Publications & Artistic Works
• 

  Selected Publications

  • Conference Papers

    • Greenup, RA, Fish, L, Rushing, C, Peppercorn, J, Hyslop, T, Zafar, Y, and Hwang, ES. "The Financial Burden of Breast Cancer Treatment." September 2017.  Link to Item
    • Campbell, BM, Thomas, SM, Ong, CT, Greenup, RA, Plichta, JK, Rosenberger, LH, Force, JM, Hyslop, T, Hwang, E-SS, and Fayanju, OM. "The epidemiology of metaplastic breast cancer: A review of 2,500 cases from the national cancer database." May 20, 2017.  Full Text  Link to Item
    • Greenup, RA, Thomas, SM, Fayanju, OM, Hyslop, T, and Hwang, E-SS. "Impact of insurance status on treatment for stage 0-IV breast cancer." May 20, 2017.  Full Text  Link to Item
    • Martin, M, Loibl, S, Hyslop, T, de la Haba-Rodriguez, J, Aktas, B, Cirrincione, C, Carrasco, EM, Mehta, K, Barry, WT, Morales, S, Carey, LA, Saenz, JAG, Partridge, A, Martinez, N, Hahn, OM, Winer, EP, Guerrero, A, Hudis, C, Casas, M, and Dickler, MN. "Evaluating the addition of bevacizumab (Bev) to endocrine therapy as first-line treatment for hormone-receptor positive (HR+)/HER2-negative advanced breast cancer (ABC): Pooled-analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials." May 20, 2017.  Full Text  Link to Item
    • Musselwhite, LW, Redding, TS, Sims, KJ, O'Leary, M, Hauser, ER, Hyslop, T, Lieberman, DA, and Provenzale, DT. "Validation of the NCI colorectal cancer risk assessment tool in the CSP 380 veterans cohort." May 20, 2017.  Full Text  Link to Item
    • Narloch, J, Luedke, C, Broadwater, G, Priedigkeit, N, Hall, A, Hyslop, T, Sammons, SL, Huggins-Puhalla, SL, Leone, JP, Ramirez, J, Kirkpatrick, JP, Ewend, MG, Fecci, PE, Brufsky, A, Lee, AV, Anders, CK, and Blackwell, KL. "Number of tumor-infiltrating lymphocytes in breast cancer brain metastases compared to matched breast primaries." May 20, 2017.  Full Text  Link to Item
    • Ong, CT, Thomas, SM, Campbell, BM, Greenup, RA, Plichta, JK, Rosenberger, LH, Force, JM, Hyslop, T, Hwang, E-SS, and Fayanju, OM. "A population-based analysis of treatment and outcomes in 2,500 meta plastic breast cancer patients." May 20, 2017.  Full Text  Link to Item
    • Plichta, JK, Thomas, SM, Fayanju, OM, Rosenberger, LH, Park, TS, Hyslop, T, Greenup, RA, and Hwang, E-SS. "Temporal associations between prognostic indicators and overall survival after breast cancer." May 20, 2017.  Full Text  Link to Item
    • Force, J, Abbott, S, Broadwater, G, Kimmick, G, Westbrook, K, Hwang, S, Kauff, N, Stashko, I, Weinhold, K, Nair, S, Hyslop, T, Blackwell, K, Castellar, E, and Marcom, P. "Abstract P2-04-19: Elucidating the tumor immune microenvironment phenotype in early stage untreated BRCA mutated breast cancer patients." February 15, 2017.  Full Text
    • Hoadley, K, Hyslop, T, Fan, C, Berry, D, Hahn, O, Tolaney, S, Sikov, W, Perou, C, and Carey, L. "Abstract PD1-03: Multivariate analysis of subtype and gene expression signatures predictive of pathologic complete response (pCR) in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)." February 15, 2017.  Full Text
    • Narloch, J, Harnden, K, Broadwater, G, Peterson, B, Hyslop, T, Kirkpatrick, J, Fecci, P, Kim, G, and Blackwell, K. "Abstract P5-08-12: HER2 status remains the primary predictor of improved survival in patients with BCBM over the past 2 decades (1996-2015)." February 15, 2017.  Full Text
    • Tanioka, M, Fan, C, Carey, L, Hyslop, T, Pitcher, B, Parker, J, Hoadley, K, Henry, N, Tolaney, S, Dang, C, Krop, I, Harris, L, Berry, D, Mardis, E, Perou, C, Winer, E, and Hudis, C. "Abstract S3-05: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer." February 15, 2017.  Full Text
    • Hwang, ES, Locklear, TD, Rushing, CN, Samsa, G, Abernethy, AP, Hyslop, T, and Atisha, DM. "Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy." May 2016.  Full Text
    • Hyslop, T, Alvarado, M, Forero, A, Golshan, M, Hieken, T, Horton, J, Hudis, C, McGuire, K, Meric-Bernstam, F, Nanda, R, Zagar, T, and Hwang, S. "Abstract S3-06: Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging: Results of a secondary analysis of TBCRC 017." February 15, 2016.  Full Text
    • Palumbo, A, Michael, Y, and Hyslop, T. "Abstract 4137: Latent class model characterization of neighborhood SES: Table 1." October 1, 2014.  Full Text
    • Eberhardt, JS, Hyslop, T, Mitchell, E, Hu, H, and Rui, H. "Bayesian Belief Network Mortality Analysis of a Breast Cancer Registry Data Set." December 15, 2011.  Full Text  Link to Item
    • Witkiewicz, A, Tran, T, Er, O, Hyslop, T, and Rui, H. "Nuclear expression of transcription factors Stat5a and Stat5b confers favorable prognosis in breast cancer." May 1, 2009.  Link to Item

  • Journal Articles

    • Force, J, Howie, LJ, Abbott, SE, Bentley, R, Marcom, PK, Kimmick, G, Westbrook, K, Sammons, SL, Parks, M, Topping, DL, Emerson, R, Broadwater, G, Hyslop, T, Blackwell, KL, and Nair, SK. "Early Stage HER2-Positive Breast Cancers Not Achieving a pCR From Neoadjuvant Trastuzumab- or Pertuzumab-Based Regimens Have an Immunosuppressive Phenotype." Clinical Breast Cancer 18, no. 5 (October 2018): 410-417.  Full Text
    • Park, TS, Thomas, SM, Rosenberger, LH, Fayanju, OM, Plichta, JK, Blitzblau, RC, Ong, CT, Hyslop, T, Hwang, ES, and Greenup, RA. "The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer." Annals of Surgical Oncology 25, no. 10 (October 2018): 3019-3029.  Full Text
    • Tamirisa, N, Thomas, SM, Fayanju, OM, Greenup, RA, Rosenberger, LH, Hyslop, T, Hwang, ES, and Plichta, JK. "Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival." Annals of Surgical Oncology 25, no. 10 (October 1, 2018): 2890-2898.  Full Text
    • Chervoneva, I, Freydin, B, Hyslop, T, and Waldman, SA. "Modeling qRT-PCR dynamics with application to cancer biomarker quantification." Statistical Methods in Medical Research 27, no. 9 (September 2018): 2581-2595.  Full Text
    • Ong, CT, Campbell, BM, Thomas, SM, Greenup, RA, Plichta, JK, Rosenberger, LH, Force, J, Hall, A, Hyslop, T, Hwang, ES, and Fayanju, OM. "Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database." Annals of Surgical Oncology 25, no. 8 (August 2018): 2249-2260.  Full Text
    • Freedman, JA, Wang, Y, Li, X, Liu, H, Moorman, PG, George, DJ, Lee, NH, Hyslop, T, Wei, Q, and Patierno, SR. "Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival." Carcinogenesis 39, no. 7 (July 2018): 879-888.  Full Text
    • Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Reply to: "Surgeon Volume Threshold for Total Thyroidectomy"." Annals of Surgery 267, no. 4 (April 2018): e78-e79.  Full Text
    • "Role of Preoperative Variables in Reducing the Rate of Occult Invasive Disease for Women Considering Active Surveillance for Ductal Carcinoma In Situ." JAMA surgery 153, no. 3 (March 2018): 290-291.  Full Text
    • Magbanua, MJM, Rugo, HS, Wolf, DM, Hauranieh, L, Roy, R, Pendyala, P, Sosa, EV, Scott, JH, Lee, JS, Pitcher, B, Hyslop, T, Barry, WT, Isakoff, SJ, Dickler, M, Van't Veer, L, and Park, JW. "Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 24, no. 6 (March 2018): 1486-1499.  Full Text
    • Greenup, RA, Obeng-Gyasi, S, Thomas, S, Houck, K, Lane, WO, Blitzblau, RC, Hyslop, T, and Hwang, ES. "The Effect of Hospital Volume on Breast Cancer Mortality." Annals of Surgery 267, no. 2 (February 2018): 375-381.  Full Text
    • Xu, Y, Wang, Y, Liu, H, Shi, Q, Zhu, D, Amos, CI, Fang, S, Lee, JE, Hyslop, T, Li, X, Han, J, and Wei, Q. "Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival." Molecular carcinogenesis 57, no. 1 (January 2018): 22-31.  Full Text
    • Lane, WO, Thomas, SM, Blitzblau, RC, Plichta, JK, Rosenberger, LH, Fayanju, OM, Hyslop, T, Hwang, ES, and Greenup, RA. "Surgical Resection of the Primary Tumor in Women With De Novo Stage IV Breast Cancer: Contemporary Practice Patterns and Survival Analysis." Annals of surgery (December 7, 2017).  Full Text
    • Ong, CT, Thomas, SM, Blitzblau, RC, Fayanju, OM, Park, TS, Plichta, JK, Rosenberger, LH, Hyslop, T, Shelley Hwang, E, and Greenup, RA. "Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011." Annals of Surgical Oncology 24, no. 12 (November 2017): 3559-3566.  Full Text
    • Adam, MA, Thomas, S, Roman, SA, Hyslop, T, and Sosa, JA. "Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer." Jama Surgery 152, no. 9 (September 2017): 869-876.  Full Text
    • Li, P, Wuthrick, E, Rappaport, JA, Kraft, C, Lin, JE, Marszalowicz, G, Snook, AE, Zhan, T, Hyslop, TM, and Waldman, SA. "GUCY2C Signaling Opposes the Acute Radiation-Induced GI Syndrome." Cancer Research 77, no. 18 (September 2017): 5095-5106.  Full Text
    • Liu, S, Wang, Y, Xue, W, Liu, H, Xu, Y, Shi, Q, Wu, W, Zhu, D, Amos, CI, Fang, S, Lee, JE, Hyslop, T, Li, Y, Han, J, and Wei, Q. "Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma-specific survival." International Journal of Cancer 141, no. 4 (August 2017): 721-730.  Full Text
    • Wang, Y, Freedman, JA, Liu, H, Moorman, PG, Hyslop, T, George, DJ, Lee, NH, Patierno, SR, and Wei, Q. "Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer." International Journal of Cancer 141, no. 4 (August 2017): 731-743.  Full Text
    • Anand, S, Thomas, S, Hyslop, T, Adcock, J, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 7 (July 2017): 1151-1157.  Full Text
    • Cheng, Q, Li, X, Acharya, CR, Hyslop, T, and Sosa, JA. "A novel integrative risk index of papillary thyroid cancer progression combining genomic alterations and clinical factors." Oncotarget 8, no. 10 (March 2017): 16690-16703.  Full Text
    • Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?." Annals of Surgery 265, no. 2 (February 2017): 402-407.  Full Text
    • Adam, MA, Thomas, S, Hyslop, T, Scheri, RP, Roman, SA, and Sosa, JA. "Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 36 (December 2016): 4415-4420.  Full Text
    • Hwang, ES, and Hyslop, T. "Reply to J. Heil et al." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 34 (December 2016): 4192-null. (Letter)  Full Text
    • Snook, AE, Baybutt, TR, Hyslop, T, and Waldman, SA. "Preclinical Evaluation of a Replication-Deficient Recombinant Adenovirus Serotype 5 Vaccine Expressing Guanylate Cyclase C and the PADRE T-helper Epitope." Human gene therapy methods 27, no. 6 (December 2016): 238-250.  Full Text
    • Kim, E, Dinan, M, Islam, KM, Fernandes, A, Schwartzberg, L, Croft, E, Brahmer, J, Mansfield, A, Hyslop, T, Burke, L, and Crawford, J. "PS01.61: Registry for the EVolution Of LUng Cancer Therapy Implementation and Outcomes Now (REVOLUTION): Registry Study in Progress: Topic: Medical Oncology." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 11, no. 11S (November 2016): S308-S309.  Full Text
    • Peck, AR, Girondo, MA, Liu, C, Kovatich, AJ, Hooke, JA, Shriver, CD, Hu, H, Mitchell, EP, Freydin, B, Hyslop, T, Chervoneva, I, and Rui, H. "Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms." Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc 29, no. 10 (October 2016): 1143-1154.  Full Text
    • Robinson, TJ, Thomas, S, Dinan, MA, Roman, S, Sosa, JA, and Hyslop, T. "How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 34, no. 28 (October 2016): 3434-3439.  Full Text
    • Sung, AD, Sung, JAM, Thomas, S, Hyslop, T, Gasparetto, C, Long, G, Rizzieri, D, Sullivan, KM, Corbet, K, Broadwater, G, Chao, NJ, and Horwitz, ME. "Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 63, no. 8 (October 2016): 999-1006.  Full Text
    • Hwang, ES, Locklear, TD, Rushing, CN, Samsa, G, Abernethy, AP, Hyslop, T, and Atisha, DM. "Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy." JOURNAL OF CLINICAL ONCOLOGY 34, no. 13 (May 1, 2016): 1518-+.  Full Text  Link to Item
    • Lai, Y, Wang, C, Civan, JM, Palazzo, JP, Ye, Z, Hyslop, T, Lin, J, Myers, RE, Li, B, Jiang, B, Sama, A, Xing, J, and Yang, H. "Effects of Cancer Stage and Treatment Differences on Racial Disparities in Survival From Colon Cancer: A United States Population-Based Study." Gastroenterology 150, no. 5 (May 2016): 1135-1146.  Full Text
    • Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?." Annals of Surgery (March 8, 2016).
    • Goodman, CR, Sato, T, Peck, AR, Girondo, MA, Yang, N, Liu, C, Yanac, AF, Kovatich, AJ, Hooke, JA, Shriver, CD, Mitchell, EP, Hyslop, T, and Rui, H. "Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism." Oncogene 35, no. 11 (March 2016): 1373-1385.  Full Text
    • Palumbo, A, Michael, Y, and Hyslop, T. "Latent class model characterization of neighborhood socioeconomic status." Cancer causes & control : CCC 27, no. 3 (March 2016): 445-452.  Full Text
    • He, K, Li, Y, Zhu, J, Liu, H, Lee, JE, Amos, CI, Hyslop, T, Jin, J, Lin, H, Wei, Q, and Li, Y. "Component-wise gradient boosting and false discovery control in survival analysis with high-dimensional covariates." Bioinformatics (Oxford, England) 32, no. 1 (January 2016): 50-57.  Full Text  Open Access Copy
    • Lin, JE, Colon-Gonzalez, F, Blomain, E, Kim, GW, Aing, A, Stoecker, B, Rock, J, Snook, AE, Zhan, T, Hyslop, TM, Tomczak, M, Blumberg, RS, and Waldman, SA. "Obesity-Induced Colorectal Cancer Is Driven by Caloric Silencing of the Guanylin-GUCY2C Paracrine Signaling Axis." Cancer Research 76, no. 2 (January 2016): 339-346.  Full Text
    • Mu, Z, Wang, C, Ye, Z, Austin, L, Civan, J, Hyslop, T, Palazzo, JP, Jaslow, R, Li, B, Myers, RE, Jiang, J, Xing, J, Yang, H, and Cristofanilli, M. "Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer." Breast Cancer Research and Treatment 154, no. 3 (December 2015): 563-571.  Full Text
    • Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Reed, SD, Scheri, RP, Hyslop, T, Roman, SA, and Sosa, JA. "Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 33, no. 21 (July 2015): 2370-2375.  Full Text
    • Showalter, TN, Hegarty, SE, Rabinowitz, C, Maio, V, Hyslop, T, Dicker, AP, and Louis, DZ. "Assessing adverse events of postprostatectomy radiation therapy for prostate cancer: evaluation of outcomes in the Regione Emilia-Romagna, Italy." International journal of radiation oncology, biology, physics 91, no. 4 (March 2015): 752-759.  Full Text
    • Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years." The Journal of Clinical Endocrinology and Metabolism 100, no. 1 (January 2015): 115-121.  Full Text
    • Adam, MA, Pura, J, Goffredo, P, Dinan, MA, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Impact of extent of surgery on survival for papillary thyroid cancer patients younger than 45 years." Journal of Clinical Endocrinology and Metabolism 100, no. 1 (2015): 115-121.  Full Text
    • Hegarty, SE, Hyslop, T, Dicker, AP, and Showalter, TN. "Radiation therapy after radical prostatectomy for prostate cancer: evaluation of complications and influence of radiation timing on outcomes in a large, population-based cohort." Plos One 10, no. 2 (January 2015): e0118430-null.  Full Text
    • Lin, J, Deng, A, Hoffman-Censits, J, Gibney, G, Hyslop, T, Miller, B, Kilpatrick, D, Jabbour, S, and Kevin Kelly, W. "An open label randomized phase II study of pasireotide with or without everolimus in castrate-resistant chemotherapy-naïve prostate cancer patients." Cancer Treatment Communications 4 (2015): 192-195.  Full Text
    • Wang, C, Civan, J, Lai, Y, Cristofanilli, M, Hyslop, T, Palazzo, JP, Myers, RE, Li, B, Ye, Z, Zhang, K, Xing, J, and Yang, H. "Racial disparity in breast cancer survival: the impact of pre-treatment hematologic variables." Cancer causes & control : CCC 26, no. 1 (January 2015): 45-56.  Full Text
    • Zhang, K, Lai, Y, Axelrod, R, Campling, B, Hyslop, T, Civan, J, Solomides, C, Myers, RE, Lu, B, Bar Ad, V, Li, B, Ye, Z, and Yang, H. "Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests." International Journal of Cancer 136, no. 2 (January 1, 2015): 382-391.  Full Text
    • Wilson, C, Lin, JE, Li, P, Snook, AE, Gong, J, Sato, T, Liu, C, Girondo, MA, Rui, H, Hyslop, T, and Waldman, SA. "The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer." Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 23, no. 11 (November 2014): 2328-2337.  Full Text
    • Chen, Y, Kovatich, A, Fantacone-Campbell, J, Hooke, J, Kvecher, L, Kovatich, A, Gallagher, C, Hueman, M, Hyslop, T, Mural, R, Shriver, C, Rui, H, and Hu, H. "Abstract P4-06-09: HER2+ and HER2- luminal B subtypes have similar overall survival and histologic grade distributions." Cancer Research 73, no. 24 Supplement (December 15, 2013): P4-06-09-P4-06-09.  Full Text
    • Girondo, M, Peck, A, Freydin, B, Chervoneva, I, Hyslop, T, Kovatich, A, Hooke, J, Shriver, C, Mitchell, E, and Rui, H. "Abstract P1-08-20: Increased risk of hormone therapy failure in breast cancers expressing low phospho-Stat5: Validation of quantitative immunofluorescence assay parameters." Cancer Research 73, no. 24 Supplement (December 15, 2013): P1-08-20-P1-08-20.  Full Text
    • Kovatich, A, Chen, Y, Fantacone-Campbell, J, Wareham, J, Tafra, L, Kvecher, L, Hyslop, T, Hooke, J, Rui, H, Shriver, C, Mural, R, and Hu, H. "Abstract P4-06-03: Assays on core biopsies and surgically resected tumors may result in different subtyping of the invasive breast cancer from the same patient:." Cancer Research 73, no. 24 Supplement (December 15, 2013): P4-06-03-P4-06-03.  Full Text
    • Hyslop, T, Michael, Y, Avery, T, and Rui, H. "Population and target considerations for triple-negative breast cancer clinical trials." Biomarkers in Medicine 7, no. 1 (February 2013): 11-21. (Review)  Full Text
    • Lin, JE, Snook, AE, Li, P, Stoecker, BA, Kim, GW, Magee, MS, Garcia, AVM, Valentino, MA, Hyslop, T, Schulz, S, and Waldman, SA. "GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity." Plos One 7, no. 2 (January 2012): e31686-null.  Full Text
    • Peck, A, Witkiewicz, A, Liu, C, Klimowicz, A, Stringer, G, Pequignot, E, Freydin, B, Yang, N, Tran, T, Rosenberg, A, Hooke, J, Kovatich, A, Shriver, C, Rimm, D, Magliocco, A, Hyslop, T, and Rui, H. "P1-06-24: Nuclear Localization of Stat5a Predicts Response to Antiestrogen Therapy and Prognosis of Clinical Breast Cancer Outcome." Cancer Research 71, no. 24 Supplement (December 15, 2011): P1-06-24-P1-06-24.  Full Text
    • Peck, AR, Witkiewicz, AK, Liu, C, Stringer, GA, Klimowicz, AC, Pequignot, E, Freydin, B, Tran, TH, Yang, N, Rosenberg, AL, Hooke, JA, Kovatich, AJ, Nevalainen, MT, Shriver, CD, Hyslop, T, Sauter, G, Rimm, DL, Magliocco, AM, and Rui, H. "Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29, no. 18 (June 2011): 2448-2458.  Full Text
    • Peck, AR, Witkiewicz, AK, Liu, C, Stringer, GA, Klimowicz, AC, Pequignot, E, Freydin, B, Tran, TH, Yang, N, Rosenberg, AL, Hooke, JA, Kovatich, AJ, Nevalainen, MT, Shriver, CD, Hyslop, T, Sauter, G, Rimm, DL, Magliocco, AM, and Rui, H. "Abstract 2277: Loss of nuclear localized and tyrosine phosphorylated Stat5: A predictor of poor clinical outcome and increased risk of antiestrogen therapy failure in breast cancer." Cancer Research 71, no. 8 Supplement (April 15, 2011): 2277-2277.  Full Text
    • Chervoneva, I, Li, Y, Schulz, S, Croker, S, Wilson, C, Waldman, SA, and Hyslop, T. "Selection of optimal reference genes for normalization in quantitative RT-PCR." BMC bioinformatics 11 (May 14, 2010): 253-.  Full Text
    • Waldron, TJ, Soliera, AR, Zhang, Y, Martinez, R, Hyslop, T, Bender, T, and Calabretta, B. "Abstract 5061: Induction of B cell acute lymphoblastic leukemia by BCR/ABL requires c-Myb and its activation of Bmi-1." Cancer Research 70, no. 8 Supplement (April 15, 2010): 5061-5061.  Full Text
    • Lin, JE, Li, P, Snook, AE, Schulz, S, Dasgupta, A, Hyslop, TM, Gibbons, AV, Marszlowicz, G, Pitari, GM, and Waldman, SA. "The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling." Gastroenterology 138, no. 1 (January 2010): 241-254.  Full Text
    • Waldman, SA, Hyslop, T, Schulz, S, Barkun, A, Nielsen, K, Haaf, J, Bonaccorso, C, Li, Y, and Weinberg, DS. "Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer." JAMA 301, no. 7 (February 2009): 745-752.  Full Text
    • Yu, Z, Wang, C, Wang, M, Li, Z, Casimiro, MC, Liu, M, Wu, K, Whittle, J, Ju, X, Hyslop, T, McCue, P, and Pestell, RG. "A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation." The Journal of Cell Biology 182, no. 3 (August 2008): 509-517.  Full Text
    • Waldman, SA, Hyslop, T, Schulz, S, Nielsen, K, Haaf, J, Bonaccorso, C, Li, Y, Barkun, A, and Weinberg, D. "A prospective multicenter study of guanylyl cyclase C (GCC), quantified by the reverse transcriptase-polymerase chain reaction (qRT-PCR), as a prognostic marker of occult metastases in lymph nodes of pN0 colorectal cancer patients." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 11011-.  Link to Item
    • Witkiewicz, A, Ryder, A, Neilson, LM, Utama, FE, Tran, TH, Hyslop, T, and Rui, H. "Transcription factors Stat5a and Stat5b: Favorable prognostic markers in breast cancer." J Clin Oncol 26, no. 15_suppl (May 20, 2008): 22071-.  Link to Item
    • Chervoneva, I, Li, Y, Iglewicz, B, Waldman, S, and Hyslop, T. "Relative quantification based on logistic models for individual polymerase chain reactions." Statistics in Medicine 26, no. 30 (December 2007): 5596-5611.  Full Text
    • Calin, GA, Liu, C-G, Ferracin, M, Hyslop, T, Spizzo, R, Sevignani, C, Fabbri, M, Cimmino, A, Lee, EJ, Wojcik, SE, Shimizu, M, Tili, E, Rossi, S, Taccioli, C, Pichiorri, F, Liu, X, Zupo, S, Herlea, V, Gramantieri, L, Lanza, G, Alder, H, Rassenti, L, Volinia, S, Schmittgen, TD, Kipps, TJ, Negrini, M, and Croce, CM. "Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas." Cancer Cell 12, no. 3 (September 2007): 215-229.  Full Text
    • Chervoneva, I, Iglewicz, B, and Hyslop, T. "A general approach for two-stage analysis of multilevel clustered non-Gaussian data." Biometrics 62, no. 3 (September 2006): 752-759.  Full Text
    • Calin, GA, Sevignani, C, Dumitru, CD, Hyslop, T, Noch, E, Yendamuri, S, Shimizu, M, Rattan, S, Bullrich, F, Negrini, M, and Croce, CM. "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers." Proceedings of the National Academy of Sciences of the United States of America 101, no. 9 (March 2004): 2999-3004.  Full Text
    • Ober, C, Hyslop, T, Elias, S, Weitkamp, LR, and Hauck, WW. "Human leukocyte antigen matching and fetal loss: results of a 10 year prospective study." Human Reproduction (Oxford, England) 13, no. 1 (January 1998): 33-38.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.